Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cipla
UBS
McKinsey
QuintilesIMS
Julphar
Farmers Insurance
Argus Health
McKesson

Generated: January 20, 2019

DrugPatentWatch Database Preview

Alkem Company Profile

« Back to Dashboard

What is the competitive landscape for ALKEM, and what generic and branded alternatives to ALKEM drugs are available?

ALKEM has forty-one approved drugs.

There are seven tentative approvals on ALKEM drugs.

Summary for Alkem
US Patents:0
Tradenames:36
Ingredients:36
NDAs:41
Patent Litigation for Alkem: See patent lawsuits for Alkem

Drugs and US Patents for Alkem

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem Labs Ltd RIZATRIPTAN BENZOATE rizatriptan benzoate TABLET;ORAL 203269-002 Feb 18, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd METFORMIN HYDROCHLORIDE metformin hydrochloride TABLET, EXTENDED RELEASE;ORAL 206145-002 Oct 22, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd OLANZAPINE olanzapine TABLET;ORAL 202295-005 Oct 20, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 204453-005 Sep 28, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065496-002 Jun 7, 2010 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Chubb
Colorcon
Accenture
Federal Trade Commission
Medtronic
Harvard Business School
Boehringer Ingelheim
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.